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THE LAW GOVERNING
HUMAN EXPERIMENTATION IN QUÉBEC
by Robert P. KOURI*
This article is intended to provide an overview of the law governing
human experimentation in Quebec as such law presently stands, and to examine
certain innovations introduced by the proposed Civil Code of Québec. It
examines more particulary, the conditions under which human experimentation
may take place and the liability of the parties involved in research.
                         
Cet article constitue un survol des règles applicables en matière
d'expérimentation humaine en droit québécois actuel, ainsi qu'un examen de
certains changements apportés par le projet de Code Civil du Québec. L'article
aborde plus particulièrement les conditions susceptibles de valider
l'expérimentation humaine ainsi que la responsabilité des parties impliquées
dans la recherche.
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1. The Law Reform Commission of Canada, in its working paper entitled Biomedical
Experimentation Involving Human Subjects, (Ottawa, Law Reform Commission of Canada,
1989), refers to «respect for the dignity and autonomy of human beings» (at p. 3), an
ongoing theme in its Protection of Life Series.
2. An Act to Add the Reformed Law of Persons, Successions and Property to the Civil Code of
Québec, 1987 S.Q. c.18, assented the 15th of April 1987.
3. Bill 125, Civil Code of Québec, 1st Sess., 34th Leg. Que., 1990, presented by Gil Rémillard,
Minister of Justice, the 18th of December 1990.
INTRODUCTION
The primary purpose of this paper is to describe and analyze the law of
Quebec as it relates to research upon humans. It accepts the fundamental
premise that scientifically valid research is not merely useful, but in reality,
necessary for the development and improvement of the human condition.
Accordingly, the law must set out parameters within which research is
encouraged and not merely tolerated. This paper also postulates that as a
corollary of this premise, research must be pursued only in a manner consonant
with human integrity and dignity1. These notions in turn call into play
considerations relating to enlightened consent and to the protection of persons
who are vulnerable due to their youth, their mental incapacity or their social
status. Through an examination of Quebec positive law, we shall see if these
noble standards are met.
The legality of non-therapeutic experimentation in Quebec is presently
governed by art. 20 of the Civil Code of Lower Canada (hereinafter C.C.L.C.).
It should be emphasized at the outset that the present Civil Code is in the process
of being revised and indeed, certain provisions of the new code as they concern
experimentation have already been adopted2, but have not and will never come
into force. This somewhat unusual situation results from the fact that on the 18th
of December 1990, the Minister of Justice introduced before the National
Assembly, yet another proposed Civil Code of Québec (hereinafter C.C.Q.)
which is intended to replace the Civil Code of Lower Canada as well as those
parts of the Civil Code of Québec which have previously been adopted3.
Consequently, in order to provide as complete a picture as possible, this paper
will first describe the present state of the law concerning experimentation and
then will allude to those changes which will be brought about by this most
recent Civil Code project. Also, it should be mentioned immediately that it is
quite likely the proposed Civil Code of Québec will be amended prior to its
coming into force. Therefore, the reader is well advised to note that these
comments on the new code are based on its text as  presently drafted and must
thus be viewed as somewhat tentative.
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4. W.F. Bowker, «Experimentation on Humans and Gifts of Tissue: Articles 20-23 of the Civil
Code», (1973) 19 McGill L.J. 161 at p. 166; J.-L. Baudouin, «L'expérimentation sur les
humains: un conflit de valeurs», (1981) 26 McGill L.J. 809 at p. 819; contra: F. Heleine, «Le
dogme de l'intangibilité du corps humain et ses atteintes normalisées dans le droit des
obligations du Québec contemporain», (1976) 36 R. du B. 2 at pp. 29-30. In connection with
the distinctions between therapeutic and non-therapeutic research and the problems related
This study is divided into three parts; the first dealing with the
conditions imposed by law for effecting research on humans, the second
involving issues of liability, and the third describing the proposed revision of the
law on experimentation, insisting more particularly on the changes which these
revisions will bring to present law.
A - Conditions under which human experimentation may take place
Looking at the law of Quebec as it presently stands, art. 20 C.C.L.C.
reads as follows:
«A person of full age may consent in writing to disposal inter vivos of
a part of his body or submit to an experiment provided that the risk
assumed is not disproportionate to the benefit anticipated.
A minor capable of discernment may do likewise with the
authorization  of a judge of the Superior Court and with the consent of
the person having parental authority, provided that no serious risk to
his health results therefrom.
The alienation must be gratuitous unless its object is a part of the body
susceptible of regeneration.
The consent must be in writing; it may be revoked in the same way.»
As may be noted, the conditions enumerated in art. 20 involve issues of
consent as well as the relationship between the potential risks and the benefits
sought through experimentation. Before dealing with these aspects, there are two
preliminary questions which must be addressed and concerning which the code
is somewhat reticent.
The first relates to the type of experiment to which art. 20 is deemed to
apply. Generally speaking, the notion of research can pertain to both therapeutic
and to non-therapeutic experimentation, the distinction between these two
branches being founded on the presence or absence of direct therapeutic benefit
for the patient. There is some debate amongst Quebec legal writers as to whether
the provisions of art. 20 C.C.L.C. are intended to apply to experimentation in all
its forms or merely to non-therapeutic or purely scientific research4. The
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thereto, we highly recommend an article written by M.A. Somerville entitled «Therapeutic
and Non-Therapeutic Medical Procedures - What are the Distinctions?», (1981) 2 Health
Law in Canada 85.
5. A. Mayrand, L'inviolabilité de la personne humaine, Montréal, Wilson & Lafleur, 1975 at
p. 16, no 6.
6. Zimmer v. Ringrose, (1979) 89 D.L.R. 3d. 646 (Alberta Trial Division), (1981)  124 D.L.R.
3d. 215 (C.A.). In the Court of Appeal, it was decided that although sterilization by silver
nitrate was innovative rather than experimental, it was viewed as a therapeutic act. In
Cryderman v. Ringrose, [1977] 3 W.W.R. 109; [1978] 3 W.W.R. 481, (1979) 89 D.L.R. 3d.
32 ( Alberta Supreme Court, Appellate Division), the Court treated the sterilization method
as experimental.
7. According to A. Mayrand, op. cit. supra note 5 at p. 17, no 8, the law has always admitted
the possibility for an individual to allow infringements to one's integrity when they were in
pursuit of a personal advantage or benefit.
8. In practice, the only consequences of this finding would relate to the requirement of a
writing as a condition of validity, and to allowing certain non-therapeutic acts to be
performed on incapable or protected persons, whereas the other rules pertaining to
enlightened consent and to the evaluation of risk and benefit would be the same since they
are straightforward applications of general legal principles.
predominant opinion favours restricting the application of art. 20 only to
research of a non-therapeutic nature. The basis for this position is grounded on
the concept that art. 20 is destined to regulate certain medical acts which do not
inure to the benefit of the person whose integrity is in question, except possibly
in an indirect manner5. However, upon closer examination, it may be perceived
that this bipartite division between therapeutic and non-therapeutic
experimentation lacks nuance since non-therapeutic research can be pursued for
reasons not entirely of an unselfish nature. For example, a patient undergoing
purely contraceptive sterilization6 or cosmetic surgery could be willing to submit
to an innovative instead of a standard surgical procedure, provided the desired
end result were attained. As this illustrates, although the intent is not therapeutic,
the patient is actuated primarily by considerations relating to direct personal
benefit.
Is it appropriate therefore that this type of activity be placed on the same
footing as experimentation destined to increase knowledge or advance medical
science without conferring a direct benefit upon the research subject?
If one bear in mind that the provisions of art. 20 C.C.L.C. were adopted
in order to validate infringements of a person's physical integrity for the
advantage of others7, this would seem to indicate that non-therapeutic acts of an
experimental nature intended for the immediate benefit of the patient would best
be governed by the droit commun rather than by the exceptional rules of this
article of the Civil Code8.
The second controversial aspect which is not clearly dealt with by the
code relates to the question of altruism in experimentation. Must the consent of
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9. A. Mayrand, op. cit. supra note 5 at pp. 81-82, no 61; F. Héleine, loc. cit. supra note 4 at pp.
62-63; P.-A. Crépeau, «Le consentement du mineur en matière de soins et traitements
médicaux ou chirurgicaux selon le droit civil canadien», (1974) 52 Can. Bar. Rev. 247 at p.
258; A. Lajoie, P. Molinari, J.-M. Auby, Traité de droit de la santé et des services sociaux,
Montréal, Presses de l'Université de Montréal, 1981 at pp. 362-363, no 583.
10. Committee on the Law of Civil Rights and Duties, Report on the Recognition of Certain
Rights Concerning the Human Body, (Montréal, Civil Code Revision Office, 1971) at pp.
6-7.
11. Québec, Assemblée Nationale, Journal des débats at p. 4551 (30 Nov. 1971).
the volunteer be «untainted» by economic incentives or can a person derive a
financial benefit from his or her participation in an experiment?
Although art. 20 forbids any remuneration for the alienation of human
organs or tissue unless they are susceptible of regeneration, it does not prohibit
payment for participation in experimentation9. Interestingly enough, the present
text of art. 20 constitutes a substantial departure from the text originally
proposed by the Civil Code Revision Office which would have banned all forms
of venality both in matters of organ or tissue donation as well as in cases of
experimentation10. However, as the proposed law was being debated before the
National Assembly, the Canadian Red Cross requested that it be modified to
allow for the remuneration of blood donors11. While heeding this suggestion, the
National Assembly added to projected art. 20 C.C.L.C. a provision that
alienations of human tissue would have to be gratuitous unless involving body
parts susceptible of regeneration. In so doing, it failed to address the specific
issue of rewarding volunteers for research. As a result, it may be affirmed that
Quebec law does not forbid the payment of fees or honoraria to volunteers for
experimental projects. Indeed, said sums could go beyond the mere
reimbursement of expenses or indemnification for inconvenience.
These preliminary points having been resolved, we will examine the
conditions set out by law for the validity of research on human volunteers.
  
1 - Consent - The consent of the experimental subject must not only be
free and enlightened, it must also be expressed in writing and must be provided
by a person having discernment.
i) Free and enlightened consent - It is trite to state that art. 19 C.C.L.C.
allows for the infringement of a person's integrity as long as the individual
concerned has been adequately informed of the nature and risks of the act
contemplated and has expressed a valid consent thereto. In those medically-
related matters where the goal pursued is not therapeutic in nature, the most
contentious aspect concerning the obtaining of valid consent involves the extent
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12. Dulude v. Gaudette, [1974] C.S. 618 at p. 621, Vallerand, J. (my translation). Note also art.
2.03.29 Règlement concernant le code de déontologie, (1980) 112 G.O.Q.1877. Thus the
notion of «therapeutic privilege» is excluded when the goal pursued is not the actual
treatment of a pathological state.
13. (1989) 48 C.C.L.T. 280; [1989] R.J.Q. 731, (Superior Court), L. De Blois, J.
14. (My translation). Id. C.C.L.T. at p. 303, R.J.Q. at p. 743. It is interesting to note that
Halushka v. University of Saskatchewan ((1965) 53 D.L.R. 2d 436) was cited with approval
by the court (in C.C.L.T. at pp. 302-303; in R.J.Q. at p. 742).
to which the physician or researcher must provide information to the research
subject. 
In dealing with the quality of information which must be presented to the
potential subject, Quebec jurisprudence is explicit - the experimentor must
«...reveal without reservation all the risks involved in the undertaking»12. The
goal is not to «proffer threats» nor «offer a lesson in medicine», but merely to
permit the person concerned to reflect thoroughly before risking his or her health
for non-therapeutic reasons. This obligation to inform the candidate for research
can be quite extensive. In the recent Quebec case of Weiss v. Solomon, Kaback
and the Jewish General Hospital13, the Court held that «in matters of purely
experimental research, the physician must reveal all known risks including those
which are rare or remote, especially if they may entail grave consequences»14.
The Weiss case went even further. It held that a research program as well
as activities ancillary thereto constituted a unified undertaking with the
consequence that the obligation to inform would include not only the risks
inherent in the actual experiment but also those pertaining to non-experimental
examinations or tests which serve to monitor the outcome of the research itself.
The Weiss case involved risks resulting from an injection of fluorescein in the
course of angiography in order to verify the efficacy of experimental ophthalmic
drops. Although angiography per se could be considered a routine medical
procedure, it nonetheless entailed some risk, the existence of which should have
been communicated to the patient. In the opinion of the court, this failure to
inform was a fundamental reason for holding the researcher liable.
The duty, as set out by Weiss v. Solomon, of informing the patient of all
known risks refers to all risks concerning which a reasonably competent
researcher would have been aware, given the particular scientific context. Yet,
this duty as so described raises serious questions when the research undertaken
involves, of necessity, some degree of deception. Under certain circumstances,
it seems obvious that some equivocation cannot be avoided when, for example,
blind or double blind testing occurs. In cases such as these, would Quebec law
countenance a lack of candour in the interests of science? One writer, adopting
a utilitarian approach to the question, would favour allowing this type of
The Law Governing
84 Human Experimentation (1991) 22 R.D.U.S.
in Québec
15. J.-L. Baudouin, loc. cit. supra note 4 at p. 821.
16. Ibid.
17. Charter of Human Rights and Freedoms, R.S.Q. c. C-12, sec. 49.
18. J.-L. Baudouin, loc. cit. supra note 4 at p. 823. This is an instance where the controversy
whether Reibl v. Hughes, [1980] 2 S.C.R. 880 and Hopp v. Lepp, [1980] 2 S.C.R. 192 apply
to Quebec law becomes more than a mere academic discussion. Under the Reibl rule, the
question that the court would ask would be «Had a reasonable person known the goal of the
experiment, would he or she have consented?» whereas under Quebec law, the court would
inquire whether «Had the subject known the goal of the experiment, would he or she have
consented?»; cf R.P. Kouri, «La causalité et l'obligation de renseigner en droit médical
québécois», (1987) 17 R.D.U.S. 493 and authorities cited. The Court in Weiss (op. cit. supra
note 13) adopted the in concreto criterion in order to determine whether there was causation:
«L'ensemble de la preuve permet à la Cour de conclure que Weiss n'aurait pas accepté de
participer au programme de recherche accompagné d'angiogrammes à la fluorescéine, s'il
avait été placé en présence d'une possibilité, même éloignée, de risque de décès ou même
uniquement de collapsus dû à sa cardiomyopathie hypertrophique» (in C.C.L.T. at p. 296;
in R.J.Q. at p. 742).
experiment to take place provided the risks involved remained negligible15. He
adds as a precondition that it would have to be demonstrably impossible to
properly carry out the experiment were the research subject wholly
enlightened16. Since the basic rule in research posits the requirement of fully
informing the subject, the safest approach would be to avoid deception since, in
appropriate circumstances, any intentional infringement of a persons's
inviolability would give rise to more than nominal moral and exemplary
damages17. Obviously, some modification of the law to cover this type of
situation may be deemed desirable.
In experiments involving blind and double blind testing, it may be
possible in some cases to obtain informed consent without having recourse to
actual deception. In blind tests of pharmaceutical products for example, would
it not be reasonable to argue that provided the subject were properly advised of
the research protocol and of the possibility of receiving an innocuous substance
rather than the actual product under trial, the researcher's legal obligations
would be validly fulfilled in this regard?
Finally, it should be emphasized that in the interest of maintaining an
atmosphere of mutual trust and respect for the autonomy of the subject, all
persons conducting research would have to advise the participants not only of
the risks involved but also of the scientific purposes of the experimentation. It
is evident that the reason for this prerequisite is to enable volunteers to avoid
becoming involved in research which they may find morally repugnant even
though, in the eyes of most, the goals pursued are highly ethical18.
ii) Necessity of giving consent in writing - The law specifically states
that the consent of the experimental subject must be given in writing. The
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19. F. Heleine, loc. cit. supra note 4 at p. 35; A. Mayrand, op. cit. supra note 5 at p. 44, no 35;
J.-L. Baudouin, loc. cit. supra note 4 at p. 820.
20. J.-G. Castel, «Nature and Effects of Consent with Respect to the Right to Life and the Right
to Physical and Mental Integrity in the Medical Field: Criminal and Private Law Aspects»,
(1978) 16 Alta L.R. 293 at p. 305; Baudouin, ibid.
21. F. Heleine, loc. cit. supra note 4 at pp. 35-36; Lajoie et al, op. cit. supra note 9 at p. 173, no
286; Baudouin ibid.
22. Sec. 265 Cr.C.
23. J.-L. Baudouin, loc. cit. supra note 4 at p. 820.
24. Committee on the Law of Civil Rights and Duties, op. cit. supra note 10 at p. 6.
apparent goal of this requirement is not only to lessen the chances of a volunteer
acting rashly, but also to facilitate proof that consent has indeed been given. Yet,
one may query the actual nature of the written consent. Does it constitute
fulfillment of an ad solemnitatem requirement or does it merely serve ad
probationem? It is now generally admitted in Quebec that consent in writing is
a condition of validity for any infringement of corporal integrity sanctioned by
art. 20 C.C.L.C.19. Consequently, without written permission, purely scientific
experimentation constitutes an illicit act. Nevertheless, the rather laconic
manner in which art. 20 is drafted implies that while a writing is obligatory, its
actual form remains unimportant. Thus, it is not necessary that the consent be
made before witnesses (although this precaution could prove to be useful) nor,
by the same token, is it necessary that consent be given by notarial deed.
Art. 20 goes on to mention that the revocation of consent may also be
made in writing. Some controversy surrounding the form of the revocation has
arisen in Quebec legal writing20 because a careful reading of the French version
of the Code appears to imply that consent may be revoked only in writing.
However, a consensus has emerged that this ambiguity was merely a result of
poor drafting and that the actual intent of the National Assembly was to allow
revocation of consent at any time and without formality, although preferably in
writing as a means of proof21. In any case, it should be noted that the
continuation of an experiment contrary to the wishes of the experimental
subject, whether expressed in writing or verbally, would constitute a criminal
assault22 as well as a civil delict23.
iii) Consent of a person having discernment - In its original draft of what
was to become art. 20 C.C.L.C., the Quebec Civil Code Revision Office
proposed that only capable adults be permitted to donate organs and tissue or
consent to experimentation24. In the course of the National Assembly debate on
the bill, it was decided to amend the project and extend the right to give tissue
or participate in experimentation to certain minors as long as there were no
serious risks to health involved. Another proviso added coincidently included
the requirement that the minor act with the «consent» of the person having
The Law Governing
86 Human Experimentation (1991) 22 R.D.U.S.
in Québec
25. Art. 19.3 C.C.L.C. provides: «A person who consents to or refuses care for another person
[unable to consent] is bound to act in the sole interest of that person taking into account, so
far as possible, any wishes expressed by that person.» See also M. Ouellette, «La loi sur le
curateur public et la protection des incapables», (1989) 3 C.P. du N. 1 at p. 14.
26. R.S.Q. c. P-35.
27. Id. sec. 42. The lower limit is set at fourteen years.
28. For example see Ginn v. Sisson, [1969] C.S. 585.
29. Yet in the case of Cayouette v. Mathieu, [1987] R.J.Q. 2230 (Superior Court), dealing with
an application to grant a 5 year-old child permission to give bone marrow to his 3 year-old
brother, V. Melançon, J. held that: «Donner exclusivement à ces mots 'doué de discernement'
le sens général signifiant celui qui a atteint l'âge de raison serait limiter la portée de l'article
qui traite aussi du 'bienfait' que l'on attend de l'intervention.» (at p. 2232) As a result, the
parental authority as well as with the authorization of a judge of the Superior
Court.
It is clear from the terms of arts 19.3 and 20 C.C.L.C. that adult mental
incompetents cannot be subjected to experimentation, even with the concurrence
of their legal representatives, for the simple reason that this type of activity is
not in the immediate best interest of the person unable to consent25. (We exclude
the somewhat facile notion of research helping mankind and thus indirectly
helping the experimental subject).
As for minors, the law sets out discernment as the criterion for eligibility
to participate in purely scientific research. Therefore, unlike the provisions of
the Public Health Protection Act26 which arbitrarily determine an age27 at which
a minor may, without assistance, consent to treatment required by his or her state
of health, the Civil Code does not set out an age at which a minor's integrity may
be infringed in the interest of others. In practical terms, this means that
discernment will vary from one minor to another depending upon the maturity,
intelligence and knowledge of the child involved. By thus allowing discernment
to be treated as a pure question of fact, there will always exist a degree of
uncertainty since interpretations of given fact-situations will inevitably vary
from one judge to another. 
Moreover, one may query whether the notion of discernment to which
art. 20 alludes relates to the capacity to be held civilly liable (i.e. the capacity to
discern right from wrong)28, or whether it relates to the capacity to contract (i.e.
the capacity to understand the nature of the juridical act to be entered into and
its consequences)?  When the question is presented in this manner, it becomes
obvious that the notion of discernment is not monolithic but rather is one which
varies according to the legal context under scrutiny. For example, it may be
possible for a particular child to discern right from wrong at a relatively early
age and thus be held civilly liable while this same child would not necessarily
have sufficient discernment to be bound by contract29. By the same token, could
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judge held that since the 5 year-old understood that he would be giving something to his sick
brother, he was able to understand or discern the nature of the intervention and appreciate
its advantages for his brother.
30. This is especially striking when one recalls that as a rule, minors are not allowed to make
gifts of property, cf art. 763 C.C.L.C.
31. A. Mayrand, op. cit. supra note 5, at p. 68, no 54.
32. See for example Cayouette v. Mathieu, op cit supra note 29; P. Deschamps, D. Sauvé,
«Aspects juridiques de la transplantation de moelle osseuse», (1981) Le Médecin du Québec
51.
33. One should emphasize the word «almost» since necessity constitutes a defence to having
committed an otherwise wrongful act. More particularly, when necessity is invoked as a
matter of course in all cases of this nature, then its pertinence becomes highly questionable
since the essence of necessity is that it occurs when a wrongful act is committed in order to
avoid a greater harm, and this wrongful act is the only reasonable way to avoid such harm.
See generally J.-L. Baudouin, La responsabilité civile délictuelle, 3rd ed., Cowansville, Les
Editions Yvon Blais, 1990 at p. 69, no 115 and references.
34. F. Heleine, loc. cit. supra note 4 at p. 51.
35. B. Knoppers, «Les notions d'autorisation et de consentement dans le contrat médical»,
(1978) 19 C. de D. 893.
it not be argued that the capacity to comprehend the risks and consequences of
a gift of human tissue or of participating in an experiment would have to be even
greater than for making decisions of a patrimonial nature, considering the fact
that one's actual integrity is at stake30?
One writer has suggested that it is difficult, in practical terms, to
envision a child less than fourteen years of age as having the discernment
necessary to submit to non-therapeutic experimentation31. Nevertheless, the
disquieting fact remains that a number of decisions have been rendered by
Quebec courts in which children of two, three, four and five years of age32 have
been deemed sufficiently capable of consenting to gifts of bone marrow for
purposes of transplantation into a sibling. Yet, one must place these decisions
in their proper context. In all cases, a close family relative was in immediate
danger of death, and all other potential donors were not histocompatible with the
donee. Also the risks for the donor were minimal (if one accepts general
anesthesia as entailing little risk), and the child «donor's» entourage was in
favour of the operation. One would almost tend to categorize this type of
situation as a case of necessity33. However, it seems clear that these or similar
redeeming considerations would not be present when it becomes a question of
submitting a young child to purely scientific experimentation.
In the case of older minors, art. 20 imposes the restraining influences of
parental «consent» and judicial authorization in order to protect a child having
discernment from excessive enthusiasm, generosity or lack of mature
reflection34. As one writer properly points out, there is an obvious error in the
language of this article35. The parents and a Superior Court judge may only
authorize the child having discernment to consent to the experiment. They
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36. Art. 648 C.C.Q.
37. Art. 653 C.C.Q.; art. 30 C.C.L.C.
38. See for example G. Reback, «Fetal Experimentation: Moral, Legal and Medical
Implications», (1974) 26 Stanford L.R. 1191 at pp. 1195-96; J.M. Burchell, «Non-
Therapeutic Medical Research on Children», (1978) 95 S.A.L.J. 193 at p. 196; D. Langer.
«Medical Research Involving Children: Some Legal and Ethical Issues», (1984) 36 Baylor
L.R. 1, at pp 2-6; M. Clapp, «State Prohibition of Fetal Experimentation and the
Fundamental Right of Privacy», (1988) 88 Columbia L.R. 1073 at p. 1086 et seq.
39. Report no 6, Ottawa, Minister of Supply and Services Canada, 1978.
40. Id. at p. 30.
cannot consent in his or her place. It should also be noted that the father and
mother exercise parental authority together36 and both must authorize the child
to submit to experimentation. In cases of conflict between the parents as to
whether giving their authorization would be opportune, the Civil Code states that
difficulties relating to the exercise of parental authority may be referred to the
court, which must then decide the issue in the best interest of the child37. It
seems fair to state that any disagreement between the parents would tend to
discourage the court from authorizing participation in experimentation since in
most cases, judicial conservatism would favour the safest course.
As another general condition of validity for experimentation upon
minors having discernment, the law requires that no serious risk result
therefrom. Since this aspect is pertinent to the discussion of the relationship
between risks and benefits, it will be analysed in that context (infra).
It is disturbing to note that by restricting participation in purely scientific
experimentation only to capable adults or to minors having discernment, the
present Civil Code seems to be somewhat out of touch with scientific
imperatives38. To begin with, certain highly useful experiments entail absolutely
no risk to the research subject. Is there any reason why they should be
forbidden? Moreover, in the field of pediatric medicine, research on children
remains essential. Indeed, the Medical Research Council in its report on Ethics
in Human Experimentation39 noted that a ban on all research involving persons
unable to give an informed consent,
«... would drastically curtail research on such diseases as the serious
mental illnesses, respiratory distress syndrome, childhood leukemia,
sudden infant death syndrome (crib death), cystic fibrosis and a variety
of other genetically determined diseases that affect the young and
frequently cause early death»40.
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41. [1933] S.C.R. 456. See generally, R. Kouri «Réflexions sur le statut juridique du foetus»,
(1980-81) 15 R.J.T. 193.
42. [1989] 2 S.C.R. 530.
43. Op. cit. supra note 41.
44. Op. cit. supra note 1 at pp. 54-55.
Likewise, the code is conspicuously silent regarding research on
embryos and foetuses. Can we assimilate the unborn to children lacking
discernment and extend the research ban to pregnant women or to cells fertilized
in vitro prior to implantation? Or should we lean in the opposite direction and
treat the unborn (excluding fertilized eggs in vitro) as pars viscerum matris? If
one is mindful of the celebrated Supreme Court case of Montreal Tramways Co
v. Léveillé41, which viewed an unborn child as an entity capable of sustaining an
injury for which an action would lie upon its birth, it would appear problematic
that foetuses be exposed to intrusive experimentation. If a foetus were subjected
to experimentation from which harm resulted, it is doubtful that the assent of the
mother to this research would provide the researcher with immunity from an
action in damages brought on behalf of the newborn child. Indeed, in certain
cases, the child could even sue his or her own mother for having knowingly
participated in risky experimentation.
When one refers to the more recent Supreme Court judgment in Daigle
v. Tremblay42 in which the father of an unborn child sought an injunction to
prevent the mother from obtaining an abortion, the legal situation becomes even
more clouded. Here, the Court held that until birth, the foetus enjoyed no
personality rights and its continued existence would depend upon the decision
of the mother. From this finding, it would be reasonable to infer that unless
considerations relating to public order and good morals dictated otherwise, a
pregnant woman could permit hazardous and intrusive non-therapeutic
experimentation to be performed on her foetus provided it were never allowed
to come to term. Were the foetus to be born in a viable state, it would acquire
legal status retroactively and the rule in Montreal Tramways Co v. Lévéillé43
would then apply. Consequently, the only sure way a woman could avoid
potential liability arising out of foetal experimentation would be to eventually
seek an abortion. One can only surmise that this anomaly has led the Law
Reform Commission of Canada to recommend that legislation be adopted
allowing experimentation on foetuses provided there be at most minimal risk
involved44.
2 - Proportionality between risk and benefit
Art. 20 states that human experimentation may be performed as long as
«the risk assumed is not disproportionate to the benefit anticipated». An
appreciation of the notions of risk and benefit may go beyond a simple
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45. J.-L. Baudouin, loc. cit. supra note 4 at p. 831.
46. See for example G. Mémeteau, Le droit médical, Paris, Litec, 1985 at p. 314, no 471.
47. J.-L. Baudouin, loc. cit. supra note 4 at p. 830.
48. A. Mayrand, op. cit. supra note 5 at p. 17, no 7; G. Mémeteau, loc. cit. supra note 46 at p.
335, no 498.
49. A better approach would be to refer to the notion of public order and require that the
experimentation be scientifically useful and ethically valid when no immediate benefit for
the research subject is intended. As well, the risks involved would have to be minimal.
50. Regrettably, the Law Reform Commission paper (op. cit. supra note 1 at p. 33 ) fails to
address this problem, stating merely that «When the purpose of an experiment is exclusively
scientific, such that no personal benefit can be expected by the experimental subject, 'benefit'
takes the form of an increase in learning, in scientific knowledge. The benefit becomes
general and social in nature, and society as a whole is the beneficiary.»
evaluation of the physical status of the person implicated. It may also entail an
evaluation of the psychological, affective and even social consequences for the
individual45. The law thus sets out criteria which are somewhat vague or
imprecise which, in itself, may be viewed as a mixed blessing. On the one hand,
it allows the courts a certain latitude or flexibility when called upon to judge the
behavior of researchers. Indeed, it is fair to state that in setting out such a broad
standard, the National Assembly certainly cannot be faulted for having erected
unreasonable obstacles to medical research. On the other hand, the difficulties
inherent in evaluating the risks/benefits standard are quite obvious. In some
types of research for example, how can one accurately measure the potential
risks when, by definition, experimentation aims at exploring the unknown46; any
hoped-for benefit being only hypothetical or perhaps merely eventual? As well,
while not an unworthy goal in itself, any advantage derived from purely
scientific research would benefit humanity in general47 rather than the research
subject in particular. Yet, legally speaking, any appreciation of the notion of risk
in proportion to benefit must relate to the situation of the individual directly
concerned48. Aside from the satisfaction derived from having performed an
altruistic act or even of having earned some monetary reward through
participation in a research project, how can such «benefits» outweigh the
substantial risks involved in many types of experimentation? As a result, it may
be argued that the utilization of a risk/benefit standard becomes downright
misleading in non-therapeutic circumstances49. Nevertheless, the terms of art.
20 remain unequivocal - one may perform clinical research provided, inter alia
there is a preponderance of benefit over risk50.
Taken literally, this would mean that as long as the benefits outweighed
the risks, almost any risk could be incurred. For example, it could be argued that
a very hazardous non-therapeutic experiment would be legitimized by an
important potential benefit for humanity to be derived therefrom. Fortunately,
the law is not so simplistic in its application. Public order establishes a limit as
to the degree of risk to which one may be exposed no matter how great the
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51. The Law Reform Commission (id at p. 34 ) evaluates risk both in terms of its seriousness as
well as in terms of its probability of occurring.
52. Op. cit. supra note 17.
53. Canadian Charter of Rights and Freedoms, Canada Act 1982, Schedule B, 1982 (U.K.)
c.11.
54. J.-L. Baudouin, loc. cit. supra note 4 at p. 826.
55. Cf A. Mayrand, op. cit. supra note 5 at pp. 67-68, no. 54; F. Héleine, loc. cit. supra note 4
at p. 54; A. Lajoie et al. op. cit. supra note 9 at p. 178, no 291.
56. P.-A. Crépeau, loc. cit. supra note 9 at p. 257.
anticipated benefit51. Since the rule of inviolability set out in art. 19 C.C.L.C. as
well as in sec. 1 of the Quebec Charter of Human Rights and Freedoms52 and
sec. 7 of the Canadian Charter of Rights and Freedoms53, has as primary goal
the protection of the individual, the magnitude of any risk which may be
assumed must remain quite limited.
With regard to experiments relating to minors having discernment, we
have already alluded to the legal requirement that no serious risk to the minor's
health may result therefrom. Does this standard replace that of comparing risk
to benefit already used in conjunction with experimentation on capable adults?
While this opinion is entertained by some54, it is felt generally that this
restriction merely lowers the limit concerning the extent to which risks can be
assumed in proportion to benefits55. Thus hypothetically, an experiment entailing
no forseeable advantage or usefulness cannot be validly performed even if it
does not expose the minor child to any risk. Likewise, an experiment holding out
great promise for scientific progress but which exposes the minor to serious risks
cannot be undertaken.
It should be noted that the duty of evaluating the risks and benefits,
whether for adults or for minors having discernment, must be assumed by the
person performing the experiment56, since it is this person whose liability will
be incurred by any violation of art. 20 C.C.L.C.
B - Liability of the parties involved in research
Before examining the particular situations of the various parties directly
or indirectly involved in research, the following observations must be made. To
begin with, this paper will not review all aspects of medical liability such as
issues of confidentiality, abandonment, proof by presumptions of fact etc. The
reader may refer to the usual doctrinal sources and to the principles generally
applicable to medical malpractice litigation.
Another preliminary aspect to be dealt with is that of prescription. Art.
2260a C.C.L.C. reads as follows:
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57. Cf Brochu v. Auger, [1981] C.S. 971; L.-H. Richard, La responsabilité professionnelle du
dentiste, Sherbrooke, Les Editions Revue de Droit, 1986 at p. 63, note 323.
58. Charter of Human Rights and Freedoms, op. cit. supra note 17, sec 49.
59. Art. 2262(1) C.C.L.C.
60. Art. 2261(2) C.C.L.C.
61. Art. 2242 C.C.L.C.
62. See generally, A. Bernardot, R. Kouri; La responsabilité civile médicale, Sherbrooke,
Editions Revue de Droit, 1980 at p. 61, no 88 et seq.
63. Potvin v. Stipetic, [1989] R.J.Q. 777 ( C. A.)
«In matters of medical or hospital responsibility, the action in
indemnity for bodily or mental prejudice caused to a patient is
prescribed by three years from the date of the fault.
However, if the prejudice becomes apparent gradually, the delay runs
only from the day on which it first appeared.»
Although the researcher need not be a health professional nor the
research subject a patient in the strictest sense, it is fair to state that since
Quebec courts have tended to regroup all malpractice litigation relating to
medicine under this provision57, liability from non-therapeutic research would
be subject to a three year prescriptive period. Yet, the apparent generality of this
three year rule must be qualified. It applies  only to recourses for «bodily or
mental prejudice» caused to the victim. As an exceptional provision, it would
not pertain to certain actions for moral damages caused by medical fault. An
example which comes to mind would be an intentional breach of confidentiality
which could cause harm to reputation and would even give rise to exemplary
damages58. In this type of situation, the prescriptive period would be one59 or two
years60 in delictual or quasi-delictual matters, and thirty years61 in cases of
contractual liability62.
Finally, although the Court of Appeal has held recently that non-liability
clauses pertaining to bodily injury were not contrary to public order and good
morals63, it should be noted nonetheless that because of specific Health Law
legislation, stipulations excluding the liability of certain researchers or
institutions would be considered void in Quebec. According to the Health
Services and Social Services Act,
«No establishment, nor its directors, employees or agents, nor any
professional may solicit a renunciation by any person or his agents  of
the responsibility resulting from professional fault or resulting from
the hospitalization or lodging of such person, or from medical
examinations, treatments or surgical operations.
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64. An Act Respecting Health Services and Social Services, R.S.Q. c.S-5, sec 127. At the time
of writing, this law was in the process of undergoing revision. This revision has since been
completed cf An Act Respecting Health Services and Social Services and Amending Various
Legislation, S.Q. 1991, c. 42, adopted the 28th of August 1991 and assented to the 4th of
September 1991. This rule is now expressed in sec. 16 of the revised act.
65. Beausoleil v. Communauté des Soeurs de la Charité de la Providence, [1965] B.R. 37.
66. Op. cit. supra note 13.
67. Id. at p. 300 (C.C.L.T.), or at p. 741 ( R.J.Q.) 
68. P.-A. Crépeau, «La responsabilité civile de l'établissement hospitalier en droit civil
canadien», (1981) 26 McGill L.J. 673 at p. 722.
69. See Lapointe v. Hôpital Le Gardeur, [1989] R.J.Q. 2619 ( C.A.) at pp. 2641-2642 (opinion
of LeBel, J.).
If such renunciation is made, it shall be void»64.
For the purposes of this paper, our discussion of civil responsibility will
be limited to the liability  of the researcher, the institution at which research is
taking place, and the research subject.
1 - The Researcher - The researcher's liability may be either contractual
or extra-contractual in nature. It is contractual when a valid contract to perform
research on a human subject has been formed with a particular individual. This
type of liability would be encountered, for instance, in cases where the consent
obtained was not sufficiently enlightened or where the research was carried out
in a negligent fashion.
Delictual or quasi-delictual liability arises when the subject has
withdrawn consent and the researcher proceeds in spite of this refusal to
participate65, or where a requirement for the validity of experimentation has not
been observed, e.g. the failure to obtain consent in writing.
The scope of liability of the researcher in charge of a project may be
quite extensive. The Weiss case66 enunciated the principle that the person
responsible for the research protocol is bound to ensure that respect for the
security and integrity of the research subject is maintained during the whole
course of the experiment, including during all verification and diagnostic
procedures effected in conjunction with the actual research67. This implies that
the researcher would be liable not only for his or her personal acts or omissions,
but also for the activities of the individual members of the research team through
application of the maxim qui facit per alium facit per se68. Indeed, in law, when
a debtor invites third parties to fulfill his or her contractual obligations, it is
logical that non-fulfillment of this duty by a third party will engage the
contractual liability of the primary debtor69. In addition to a recourse against the
researcher, the victim would also have a quasi-delictual claim under art. 1053
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70. Art. 19 C.C.L.C.
71. Indeed, in cases of medical malpractice, it has been decided that when a nurse performs acts
of a medical nature which only a physician can accomplish, or when a general practitioner
performs specialized medical acts, these persons will, in the interest of the patient, be held
to the higher standard, cf A. Bernardot & R. Kouri, op. cit. supra note 62 at pp. 13-14, no
22 and references therein cited.
72. Note that we refer to the «procedure» or actual experiment as opposed to, for example, the
testing of an experimental medication in capsule form and which has been administered by
a nurse at the request of the physician-researcher. In this case, it is obvious that the nurse
would not be liable for the experimental aspect of the intervention.
C.C.L.C. against the person actually causing the harm, such as a research
assistant, nurse, technician or other member of the team.
One problem in medical research which remains to be resolved concerns
the standard according to which the researcher's behavior is to be judged. Would
it be realistic to compare the actions of a physician engaged in research to those
of a reasonable physician involved in «ordinary» practice? Wouldn't a higher
standard be more appropriate, given the  circumstances in which the harm
occurs? In Quebec law, taking as analogy the liability of surgeons performing
purely cosmetic surgery as compared to that of surgeons carrying out therapeutic
operations, the courts have refused to set up stricter standards by which to
evaluate the performance of non-therapeutic treatment. However, as previously
indicated, the duty to inform has been viewed more stringently in circumstances
where the goal of the act was not therapeutic. It seems logical to assume that
there would probably be a similar trend in matters relating to pure
experimentation. In this connection, it should be noted that as a matter of fact,
not all medical experimentation is carried out by physicians. In such cases,
should a different, perhaps less exacting standard be imposed for example on a
person holding a doctorate in physiology but who is not a physician, than would
be expected of a medical doctor? The answer, on grounds of public order, would
likely be in the negative since a fundamental role of the law is to ensure the
protection of a person's integrity70. A variation in standard depending upon the
qualifications of the person acting, as opposed to a variation in standard
according to the activity being performed, would not be conducive to providing
equal protection to all individuals71.
Therefore, no matter who administered the experimental procedure, the
criterion for evaluating whether a fault has occurred would be the standard of a
reasonably competent, conscientious and attentive physician acting in similar
circumstances72.
2 - The Institution - There is an ongoing debate in Quebec law as to the
existence of a master and servant relationship between a physician performing
medical acts and the institution where such activities occur. The reason for this
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73. Cf A. Bernardot & R. Kouri, op. cit. supra note 62 at p. 350, no. 534 et seq.; P.-A. Crépeau,
loc. cit. supra note 68 at p. 719; J.-L. Baudouin, op. cit. supra note 33 at pp. 265-266, nos
513-514; see also Lapointe v. Hôpital Le Gardeur, op. cit. supra note 69 at p. 2639.
74. Martel v. Hôtel-Dieu St-Vallier, [1969] S.C.R. 745.
75. Even when the context of liability is extra-contractual, P.-A. Crépeau (loc. cit. supra note
68 at pp. 733-734) presents a persuasive argument based upon the qui facit per alium rule
for dispensing with the necessity of establishing a master-servant relationship as a condition
precedent for holding the hospital liable. According to Crépeau, «En ce qui concerne le fait
d'autrui, on devra admettre que la faute d'un auxiliaire, professionnel ou non, dans
l'exécution de ces prestations personnelles de soins et de services, assumées légalement par
l'établissement, entraînera la responsabilité de ce dernier, non pas comme on l'estime parfois,
sur la base plus astreignante du régime de garantie du commettant, instauré par l'article 1054,
alinéa 7 C.c., mais bien, et plus largement, sur le fondement de la responsabilité personnelle
de l'article 1053 C.c. En effet, la maxime qui agit per alium agit per se (...) ne joue pas
seulement en matière contractuelle, mais bien chaque fois qu'une obligation personnelle est
mise à la charge du débiteur, soit qu'il l'ait assumée par contrat, soit qu'elle lui ait été
imposée par la loi.» (at p. 733). While S. Nootens («La responsabilité civile du médecin
anesthésiste (2e partie)», (1989) 19 R.D.U.S. 317 at pp. 374, 375) and F. Tôth («Contrat
hospitalier moderne et ressources limitées: conséquences sur la responsabilité civile», (1990)
20 R.D.U.S. 313 at pp. 324-325) refuse to admit the validity of this point of view, D. Jutras,
in his article «Réflexions sur la réforme de la responsabilité médicale au Québec», (1990)
31 C. de D. 821 at p. 830 fails to address Crépeau's thesis. It is worthwhile recalling that
while art. 1054 para. 7 C.C.L.C. creates a regime of liability applicable to an employer or
commettant for the fault of the préposé, it is in fact a regime of liability without fault,
whereas in the case of a legal obligation to do which is imposed upon a particular person,
such person's failure to fulfill this obligation due to the act or omission of another person
acting at the behest of the primary debtor would constitute a straightforward application of
the qui facit per alium rule. Crépeau's point of view is highly plausible in cases where
medical treatment is provided in an extra-contractual context because as he properly points
out, establishments such as hospitals are under a legal duty to offer such care (loc. cit. supra
note 68 at pp. 677 - 678). But does his reasoning still hold true when the situation
contemplated is one involving pure research? A brief examination of the Health Services and
Social Services Act (op. cit. supra note 64) indicates that Crépeau's thesis does indeed
remain applicable. To begin with, the Minister of Health and Social Services has the duty
to promote research and teaching (sec. 3(f)). In order to attain this goal, establishments may,
in addition to the services which are usually offered, provide « ... teaching and research
services if bound by a contract of affiliation recognized by the Minister of Education or the
Minister of Higher Education and Science and by the Minister of Health and Social
Services...» (sec. 125 ). This leads one to believe that the mission of certain hospital centers
may be expanded to include purely scientific research. By implication therefore, sec. 4 of the
debate relates to the determination whether art. 1054 C.C.L.C. imposing
vicarious liability on a master or employer can apply in favour of a patient or
research subject. The predominant view tends toward denying such a
relationship73, although the Supreme Court of Canada has on occasion decided
the contrary74. The preferable approach would be to exclude vicarious liability
except in circumstances where the researcher was acting on the institution's
behalf rather than in pursuit of his or her personal interest. In the final analysis,
since medical liability in Quebec usually arises out of contract, it is submitted
that in most cases, a discussion of whether or not a physician is a préposé or
servant becomes somewhat less pertinent75.
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Health Services and Social Services Act would apply equally to both research subjects and
to those receiving medical treatment in such establishments. Speaking objectively however,
situations in which pure research is undertaken without a contract having previously been
entered into between the establishment and the subject or his or her representative would be
highly exceptional.
76. Op. cit. supra note 13.
77. Id. at pp. 304-305 (C.C.L.T.) and at pp. 743-744 ( R.J.Q.). While this writer would agree
with the decision that the hospital be held liable for its own fault or for the fault of its
research committee acting in the hospital's interest, the Court merely states that since the
researcher committed a fault, this negligent act would also engage the liability of the hospital
under art. 1054(7) C.C.L.C. This latter finding is somewhat paradoxical, given the fact that
there was a contract between the patient and the principal researcher.
78. Id. at p. 304 (C.C.L.T.) and at p. 744 (R.J.Q.)
79. See generally, A. Bernardot & R. Kouri, op. cit. supra note 62 at p. 219 et seq.
80. See for example Kaimowicz v. Michigan Dept. of Mental Health, (1978) 42 U.S.L.W. 2063.
See also the Règlement sur les établissements de détention, R.R.Q., 1981, c P-26, r 1, art.
21.
According to the Weiss case76, an institution would be liable not only for
the fault of the physician who actually performs the research work but also for
the negligence of its research committee in approving, for example, the research
protocol or the information to be included in the consent form77. This case also
suggests that insufficiently selective criteria for the choice of research subjects
likewise could be a source of liability of the institution through its research
committee78. Moreover, the Court in Weiss held the institution liable for failing
to have  appropriate equipment such an electrocardiograph or a defibrillator
readily accessible in cases of emergency arising during an experiment. Clearly,
the type of emergency equipment which should be available would depend upon
the kind of experiment performed and the untoward reactions which could
occur.
3 - The Research Subject - Although at first blush it appears unusual to
evoke the notion of the research subject's liability, there may arise situations in
which substantial harm could be caused to the researcher and other interested
parties due to the acts or omissions of the volunteer. This discussion centers
around the notions of compliance or collaboration. A lack of compliance on the
part of the subject could well be the source of inaccurate data, time lost, wasted
effort as well as needless expense. Compliance includes honesty and candour in
providing personal information for purposes of identification and selection of the
candidates for research. It can also take the form of active collaboration or
following instructions during the administering of the experiment itself. It could
include returning, if necessary, for any follow-up observation, testing or care79.
It should be emphasized that participation in an experiment must always
be totally voluntary, which explains why, for example, one must not use
prisoners for experimentation80, and why the experimental subject may withdraw
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81. A. Mayrand op. cit. supra note 5 at p. 83, no 62. It should be noted however, that Mayrand
was discussing a last minute refusal to go through with a promised gift of tissue. Also, it
should be recalled that the notion of abuse of rights stricto sensu is based upon something
which is done in bad faith cf. Brodeur v. Choinière, [1945] C.S. 334.
82. Op. cit. supra note 3.
his or her consent at any time. One writer suggests that even when participation
in this type of voluntary activity may be withdrawn at the last minute, should
such a refusal to continue cause damage to others, the subject could be held
liable for having abused his or her rights81. The consequences of this point of
view are troubling, especially in matters of pure research. Indeed, one would
hesitate to approve coercing ongoing participation in an experiment because of
exposure to a potential abuse of rights damages action. Between the freedom of
the individual and the possibility of causing inconvenience to others, it is felt
that participation in experimentation should be entirely voluntary and free from
fear of suit, should a change of heart occur.
C - The new law governing experimentation
As already mentioned82, the projected Civil Code of Québec sets out
rules dealing specifically with medical experimentation. The pertinent
provisions are contained in articles 20 to 24 C.C.Q., which read as follows:
«20. A person of full age who is able to give his consent may submit
to an experiment provided that the risk incurred is not disproportionate
to the benefit that can reasonably be anticipated.
21. A minor or a person of full age who is unable to give his consent
may be submitted to an experiment only in the absence of serious risk
to his health and of objection on his part, provided that he understands
the nature and consequences of the act; the consent of the person
having parental authority or of the mandatary, tutor or curator is
required.
Furthermore, a benefit to the health of the person concerned
or of persons of the same group must be expectable; in the first case,
the authorization of the court is required and in the second, the
research project as part of which the experiment is carried out must be
approved by the Minister of Health and Social Services.
Innovative care required by the state of health of a person who
submits to such care is not considered to be an experiment.
22.  A part of the body, whether an organ, tissue or other substance,
removed from a person as part of the care he receives may be used for
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83. Therapeutic experimentation can be distinguished from innovative therapy in that the former
aims at providing direct benefit to the research subject by utilizing therapeutic modalities,
any contribution to the acquisition of knowledge being secondary, whereas in the case of the
latter, which also has as its goal the direct benefit of the patient, the acquisition of knowledge
is not a mere fortuitous by-product but an end actively pursued. As we can see, the
relationship between the two is characterized by the aim of acting in the immediate  best
interest of the experimental subject. The nature of this relationship leads one to wonder why
the drafters of the proposed Civil Code have seen fit to recommend controls for the
performance of experimental therapy and not for innovative therapy since the risks are
arguably similar. Indeed, because of the interest pursued, would it not be more logical to
contemplate both activities as facets of therapy and deem them subject to the same legal
rules? On the other hand, some writers feel that since both innovative therapy and
therapeutic research constitute research, they should be subject to the rules governing
purposes of research, unless the person concerned or the person
qualified to give consent for him objects.
23.  When the court is called upon to rule on an application for
authorization with respect to the alienation of a part of the body,
medical care or an experiment, it shall obtain the opinions of experts,
of the person having parental authority, of the mandatary, of the tutor
or the curator and of the tutorship council; it may also  obtain the
opinion of any person who shows a special interest in the person
concerned by the application.
The court is also bound to obtain the opinion of the person
concerned unless that is impossible, and to respect his refusal unless
the care is required by his state of health. 
24. Consent to the alienation inter vivos of a part of a person's body,
to medical care not required by a person's state of health or to  an
experiment shall be given in writing.
It may be withdrawn at any time, even verbally.»
For purposes of our comparison with the law presently in force, we will
allude only to those aspects of the proposed legislation which constitute
substantial modifications to current law.
1 - Capacity - In a clear departure from the provisions of the Civil Code
of Lower Canada, it would become possible for an adult or minor lacking
discernment to participate in an experiment. In such cases, consent would be
supplied by an interested third party such as the person having parental
authority, the mandatary or the tutor or curator. Other conditions precedent are
also established according to the type of experimentation to be undertaken, since
the new code would explicitly regulate both therapeutic experimentation (other
than innovative therapy) and purely scientific research83. In the former situation,
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experimentation. See generally, M. Somerville, loc. cit. supra note 4 at p. 86; the Law
Reform Commission working paper on biomedical experimentation, op. cit. supra note 1 at
pp. 4-5; Medical Research Council of Canada, Guidelines on Research Involving Human
Subjects, (Ottawa, Minister of Supply and Services Canada, 1987) at p. 9.
84. Art. 18 para 2 C.C.Q.
85. Art. 19 C.C.Q.
86. Of course, the research protocol would still be subject to the controls imposed by the funding
body such as the Medical Research Council of Canada. These controls, however, derive from
the legal relationship between the researcher and the funding body, and do not affect the
legality of the research per se.
87. See generally the Medical Research Council of Canada's guidelines, op. cit. supra note 83
at pp. 32-35; B. Knoppers, Conception artificielle et responsabilité médicale, Cowansville,
Les Editions Yvon Blais Inc., 1986 at p. 5.
those entitled to act on behalf of the person under protection could do so only
with the permission of the court84.
The court, before granting authorization, first would be called upon to
consult with certain persons such as experts in the field and with the
experimental subject's representatives. It could also consult with or obtain the
advice of other interested third parties85.
Paradoxically, under this legislation, should the research subject in fact
be capable of expressing an opinion on his or her participation in an experiment,
the court would be bound to respect the subject's refusal unless the
experimentation was necessitated by that person's state of health. By definition
therefore, therapeutic experimentation implies that in almost all situations, the
incapable patient would never be allowed to refuse treatment.
As for purely scientific research, aside from the consent of those entitled
to act on behalf of the person under protection, the only other legal safeguard in
place would be the necessity of having the research project approved by the
Minister of Health and Social Services86. Court authorization would no longer
be required.
It is interesting to note that despite the pressing need for guidance on the
subject87, no indication is given by these new provisions whether research may
be performed on the unborn. On the one hand, the absence of any formal
prohibition of foetal experimentation could be interpreted as a tacit approval of
this type of act. On the other hand, it could be posited that the internal logic of
the new codal articles on consent would tend to indicate that foetuses or
embryos cannot be experimented upon, subject of course to the nuances alluded
to above in our discussion of current law. The fact that only under exceptional
circumstances would the new code allow «proxy» consents on behalf of those
who are under the law's protection, argues in favour of this latter point of view
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88. (1988) 249 Cal.Rptr. 494 (Court of Appeal); (1990) 271 Cal.Rptr. 146 (Supreme Court of
California).
89. Op. cit. supra note 42.
90. See for example the statement of Mr. Justice Vallerand in Langlois v. Meunier, [1973] C.S.
301 at p. 305: «Cet enfant à naître n'est certes pas une personne et les principes du droit civil
concernant le décès ne peuvent s'y appliquer. Il n'est pas non plus une chose, non plus qu'un
membre ou organe de sa mère. Il ne se situe, à vrai dire, dans aucune catégorie de biens ou
de personnes qu'identifie la loi.» In this case, parents were suing for damages resulting from
the still-birth of their unborn child at an advanced state of gestation, due to the fault of the
defendant. See also J.-C. Galloux, «Réflexions sur la catégorie des choses hors du
commerce: l'exemple des éléments et des produits du corps humain en droit français», (1989)
30 C. de D. 1011 at pp. 1020-1021.
91. Art. 21 C.C.Q.
since it is a fundamental rule that exceptional provisions must be interpreted
restrictively. Consequently, a cogent argument may be made that the new code
would indeed forbid foetal experimentation, at least in utero. However, the
drafting of art. 22 C.C.Q. is tantalizingly vague. At first glance, one could
dismiss this article as confirmation of the rule that once parts of the human body
are obtained as a by-product of surgical or diagnostic procedures, the average
patient is generally indifferent as to the disposition of such tissue or substances.
In other words, it codifies current practices. Perhaps some would be inclined to
view art. 22 C.C.Q. as an attempt to provide a statutory resolution to any
potential debate similar to that dealt with in the case of Moore v. Regents of the
University of California88, involving the right of a cancer patient to a portion of
the profits generated from the production and sale of a cell-line derived from his
cancer cells. But if this were the goal of art. 22, it would seem reasonable that
ownership of the human tissue or substances would have to be attributed to the
researcher, the hospital or the research institution, which in fact, art. 22 C.C.Q.
fails to do. This leads one to the only other hypothesis possible, especially in
light of Daigle v. Tremblay89. Since the Supreme Court dismissed the notion of
granting personhood to the unborn, and since under Quebec law, it would not be
appropriate to treat foetuses and embryos as objects of ownership90, the idea that
aborted foetuses could be used for research becomes plausible. By the same
token, it leads one to the conclusion that surplus fertilized ova produced in the
course of in vitro fertilization could also be used for experimentation.     
2 - Other criteria of validity for experimentation - Art. 21 C.C.Q. sets out
certain conditions which must be met before an experiment involving an
incapable person may be carried out. These include the requirement that firstly,
the experiment must be performed in the interest of the person concerned or in
the interest of persons forming part of the same group, and secondly, there must
be an absence of serious risk for that person's health91.
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The first condition relates mainly to a question of policy in order to
avoid any notion of undue exploitation of vulnerable persons. It implies, for
instance, that children may be subjects of purely scientific research provided
other children are likely to benefit therefrom. The same holds true for the
mentally deficient. However, a rule of this nature also connotes that with regard
to conditions or diseases which are not exclusive to their group, incapable
persons cannot participate in a program of experimentation. Consequently, a
mentally deficient adult cannot be experimented upon in order to determine, for
example, the causes and potential treatments for ulcerative colitis since colitis
affects all segments of the population.
This legislative acknowledgement of group solidarity among the young
or the mentally incapable suggests that scientific imperatives have dictated the
need to adopt a rule more flexible than the present prohibition on non-
therapeutic experimentation on persons lacking discernment.
The second criterion, which requires that the experiment not entail
serious risk, constitutes a major improvement upon present law since it
dispenses with the evaluation of risks for the individual in relation to the benefits
for mankind. A realistic note is introduced in that while the necessity of
experimentation is acknowledged as a matter of public policy, strict limits are
placed thereon. 
With a view to protecting vulnerable persons from undue influence or
coercion, especially in light of the legalization of certain medical acts previously
forbidden, the new code sets out stringent procedural safe-guards usually having
as their focal point the requirement that the permission of the court be secured.
Not only must the potential research subject be consulted, the court must also
obtain the opinion of others such as the person having parental authority or the
mandatary, the tutor or curator, the tutorship council as well as that of experts.
A person showing a special interest in the person involved may also be heard.
Oddly enough, no mention is made of the possibility of designating an
attorney ad litem whose sole duty would be to act on behalf of the person
concerning whom the application is made. Without desiring that the procedure
for obtaining authorization degenerate into an adversarial process, it is submitted
that greater protection for the individual would result from the efforts of a
person whose loyalties are less likely to be divided.
CONCLUSION
From this brief study of the legal aspects of experimentation, several
points necessitating clarification arise. Firstly, the law is going to have to come
to grips with the issue of non-therapeutic experimentation involving the unborn,
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92. Loi no 88-1138 du 20 décembre 1988 relative à la protection des personnes qui se prêtent
à des recherches biomédicales, J.O. 22 déc. 1988, p. 1603, J.C.P.  1989.III.62199 (emphasis
added). For an analysis of this law see, G. Mémeteau, «De quelques droits sur l'homme:
commentaire de la loi du 20 décembre 1988 relative à la protection des personnes qui se
prêtent à  des recherches biomédicales», D.S. 1990 chron.XXX, especially at p. 168  where
he quotes Mme Dorlhac as saying before the Sénat, «Pour le volontaire sain, la notion de
bénéfice escompté n'existe jamais.»
93. Op. cit. supra note 1.
both in vivo and in vitro, rather than leave this type of problem to the vagaries
of the judicial system.
Secondly, the proposed code should be modified to eliminate the
difference in approach to innovative therapy and to therapeutic experimentation.
Since both activities have as primary goal the pursuit of a benefit for the patient,
they should be classified as therapy rather than experimentation. Also it would
perhaps be advisable to retain the necessity of judicial authorization to perform
purely scientific experimentation on minors and incapable adults. The fact that
the Minister of Health and Social Services approves a research project does not
ensure that in individual cases, the rights of vulnerable persons will be
safeguarded. Moreover, one must acknowledge the danger that authorizing non-
therapeutic experimentation on incapable subjects could constitute the «thin
edge of the wedge» in which greater liberties could be taken than would have
been originally contemplated by any enabling legislation.
Thirdly, the law is going to have to deal with the incongruities inherent
in requiring that the degree of risk be commensurate with the amount of benefit
to be derived from a purely scientific experiment. How can one weigh these two
factors when the potential detriment will be assumed by one person whereas the
potential benefit will be enjoyed by others? On this point, it would be
advantageous to follow the lead of French legislation which deals squarely with
this contradiction by declaring:
«Art. L.209-2 Aucune recherche biomédicale ne peut être effectuée sur
l'être humain:
...
si le risque prévisible encouru par les personnes qui se prêtent à la
recherche est hors de proportion avec le bénéfice escompté pour ces
personnes ou l'intérêt de cette recherche»92;
The Law Reform Commission of Canada, in its working paper on
Biomedical Experimentation Involving Human Subjects93, formulates very
specific recommendations concerning the whole question of research and the
protection of the individual. While one may dispute certain recommendations
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or perhaps even the Law Reform Commission's inclination to treat as falling
under federal jurisdiction the statutory regulation of experimentation, the fact
remains that the Commissioners are correct in stating that one should not wait
for an accident or manifest abuse to occur and then have the courts indicate to
Parliament what it should have done to avoid the problem94.
